The polymer Carragelose®, a unique broadly active anti-viral compound for treating respiratory diseases that has been approved for marketing in the EU, parts of Asia and Australia as part of nasal sprays, throat sprays and lozenges. It is a sulfated polymer from red seaweed also widely used in the food industry and has GRAS status (FDA). The compound has a broad spectrum of anti-viral properties and is supported with a strong patent family.
A cold comes three days - stays three days - leaves three days.
Colds are caused by more than 200 different respiratory viruses.
Like a burr to textiles cold viruses bind to the surfaces of the upper respiratory tract.
Then the infection starts. It is time to interfere!
Sprayed into the nose Carragelose® creates a protective layer in the nasal cavity that helps to reduce the spreading and proliferation of the common cold virus.
The clotted viruses leave the body via the natural route - the cold might not even come, stay shorter or leave faster.
No Virus – No Cold – Naturally achieved
The safety and anti-viral effectiveness of Carragelose® have been established in several clinical and non-clinical trials. Three double-blind, placebo-controlled clinical trials confirmed the anti-viral effectiveness, a significant reduction of the duration of the disease, a significant reduction of viral load and a reduction of relapses.